Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$6.84
-0.02-0.29%
At close: -
$6.84
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
MiMedx Group (MDXG) Forecast
NewsEarningsMiMedx Group (MDXG) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
MiMedx Group Stock Price, Quotes and Forecasts | NASDAQ:MDXG | Benzinga
Explore MiMedx Group stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MDXG.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy MiMedx Group (MDXG) stock?
You can purchase shares of MiMedx Group (NASDAQ:MDXG) through any online brokerage.
Who are MiMedx Group (MDXG) competitors?
Other companies in MiMedx Group’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Syndax Pharmaceuticals (NASDAQ:SNDX), CareDx (NASDAQ:CDNA) and Mesoblast (NASDAQ:MESO).
What is the forecast, or price target, for MiMedx Group (MDXG) stock?
MiMedx Group has a consensus price target of $12.40.
What is the current price for MiMedx Group (MDXG)?
The stock price for MiMedx Group (NASDAQ: MDXG) is $6.84 last updated April 11, 2025 at 4:00 PM EDT.
Does MiMedx Group (MDXG) pay a dividend?
There are no upcoming dividends for MiMedx Group.
When is MiMedx Group (NASDAQ:MDXG) reporting earnings?
MiMedx Group’s Q1 earnings are confirmed for Tuesday, April 29, 2025.
Is MiMedx Group (MDXG) going to split?
There is no upcoming split for MiMedx Group.
What sector and industry does MiMedx Group (MDXG) operate in?
MiMedx Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.